Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities
Author:
Funder
National Institute of Health
American Heart Association
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12272-023-01447-0.pdf
Reference183 articles.
1. Abdollahpour-Alitappeh M, Lotfinia M, Gharibi T, Mardaneh J, Farhadihosseinabadi B, Larki P, Faghfourian B, Sepehr KS, Abbaszadeh-Goudarzi K, Abbaszadeh-Goudarzi G, Johari B, Zali MR, Bagheri N (2019) Antibody-drug conjugates (ADCs) for cancer therapy: strategies, challenges, and successes. J Cell Physiol 234:5628–5642. https://doi.org/10.1002/jcp.27419
2. Ackerman S, Pearson C, Gregorio J, Gonzalez J, Kenkel J, Hartmann F, Luo A, Ho P, LeBlanc H, Blum L, Kimmey S, Luo A, Nguyen M, Paik J, Sheu L, Ackerman B, Lee A, Li H, Melrose J, Laura R, Ramani V, Henning K, Jackson D, Safina B, Yonehiro G, Devens B, Carmi Y, Chapin S, Bendall S, Kowanetz M, Dornan D, Engleman E, Alonso M (2021) Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity. Nat Cancer 2:18–33. https://doi.org/10.1038/s43018-020-00136-x
3. Adair JR, Howard PW, Hartley JA, Williams DG, Chester KA (2012) Antibody–drug conjugates—a perfect synergy. Expert Opin Biol Ther 12:1191–1206. https://doi.org/10.1517/14712598.2012.693473
4. Adumeau P, Sharma SK, Brent C, Zeglis B (2016) Site-specifically labeled immunoconjugates for molecular imaging—part 1: cysteine residues and glycans. Mol Imaging Biol 18:1–17. https://doi.org/10.1007/s11307-015-0919-4
5. Agarwal P, Bertozzi CR (2015) Site-specific antibody–drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development. Bioconjug Chem 26:176–192. https://doi.org/10.1021/bc5004982
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS);Frontiers in Pharmacology;2024-08-20
2. Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges;Sensors;2024-08-08
3. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28
4. Implications of inflammatory cell death-PANoptosis in health and disease;Archives of Pharmacal Research;2024-07
5. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates;Journal of Chromatography B;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3